JDP Therapeutics Initiates Clinical Trial with Its Lead Candidate JDP-205
JDP Therapeutics Initiates Clinical Trial with Its Lead Candidate JDP-205 JDP Therapeutics Inc., a specialty pharmaceutical company, announced today that the first group of 12 human volunteers have been dosed JDP-205 Investigational New Drug in a phase I clinical trial without any significant adverse events. Lansdale, PA (PRWEB) April 15, 2011 JDP Therapeutics Inc., a specialty pharmaceutical company, announced today that the first group of 12 human volunteers have been dosed JDP-205 Investigational New Drug in a phase I clinical trial without any significant adverse events. This clini
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4